India Pharma Outlook Team | Monday, 16 May 2022
Biological E (BE) produced Corbevax vaccine shot for children has reduced the price of its COVID-19 vaccine, from Rs. 840 to Rs.250 a dose inclusive of GST,for private COVID-19 vaccination centres.
For the end user,the price would be Rs.400 a dose, including taxes and administration charges, the Hyderabad based vaccine maker informed Monday. "BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children
against the virus.The decision comes within weeks of Biological E. Limited receiving Emergency Use Authorization (EUA) for children between 5 and 12 years of age. The previous private market price for the vaccine was Rs.990 a dose including taxes and vaccine administration charges," the pharma company informed. Further added that the Corbevax vaccination slot can be booked through the Co-WIN app or the Co-WIN portal for children aged 12 to 17.
So far, 43.9 million doses have been administered to children across the country and the pharma company has supplied close to 100 million doses to the Government of India. Biological E. Limited, in collaboration with Texas Children's Hospital and Baylor College of Medicine, has developed a recombinant protein sub-unit vaccine for the novel coronavirus, Corbevax .Prior to receiving EUA for vaccination, the company conducted Phase II and III multicentre clinical trials in 624 children aged 5-12 and 12-18.
.jpg)
